Johan Filip Vansteenkiste (Johan Vansteenkiste, Johan F Vansteenkiste)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 6

Top Venues

Nature medicine

Expert review of anticancer therapy

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Acta oncologica (Stockholm, Sweden)

Catholic University Leuven - KU Leuven

Catholic University Leuven - KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Catholic University Leuven - KU Leuven

Belgium

Professor :: Clinical and experimental medicine

University Hospital KU Leuven

Belgium

Head of clinic :: Pulmonology / Respiratory Oncology

Education History

Catholic University Leuven - KU Leuven

Belgium

PHD :: Faculty of Medicine

Publications

David R Spigel, Corinne Faivre-Finn, Jhanelle E Gray, David Vicente, David Planchard, Luis G Paz-Ares, Johan Filip Vansteenkiste, Marina-Chiara Garassino, Rina Hui, Xavier Quantin, Andreas Rimner, Yi-Long Wu, Mustafa Özgüroğlu, Ki Hyeong Lee, Terufumi Kato, Maike de Wit, Takayasu Kurata, Martin Reck, Byoung Chul Cho, Suresh Senan, Jarushka Naidoo, Helen Mann, Michael Newton, Piruntha Thiyagarajah, Scott J Antonia
Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (12) (2022)
Anne Sibille, Frederique Bustin, Luciano Carestia, Gaetan Catala, Christophe Compère, Kristof Cuppens, Benoit Colinet, Stephanie Coulon, Nele De Brucker, Lore Decoster, Lynn Decoster, Ingel Demedts, Sofie Derijcke, Koen Deschepper, Danny Galdermans, Annelies Janssens, Sebahat Ocak, Christel Oyen, Karin Pat, Thierry Pieters, Vincent Pruniau, Veerle Surmont, Saar Vandekeere, Johan Filip Vansteenkiste
A prospective, multicenter, noninterventional study of decision factors in the first-line treatment of metastatic non-small cell lung cancer. Acta oncologica (Stockholm, Sweden) 61 (6) (2022)
Benoît Colinet, Jan P Van Meerbeeck, Tine Cuppens, Johan Filip Vansteenkiste
Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data. Acta clinica Belgica 76 (3) (2020)
Benjamin Dizier, Andrea Callegaro, Muriel Debois, Brigitte Dreno, Peter Hersey, Helen J Gogas, John M Kirkwood, Johan Filip Vansteenkiste, Lecia V Sequist, Djordje Atanackovic, Jelle Goeman, Hans van Houwelingen, Susana Salceda, Fawn Wang, Patrick Therasse, Channa Debruyne, Bart Spiessens, Vincent G Brichard, Jamila Louahed, Fernando Ulloa-Montoya
A Th1/IFNγ Gene Signature Is Prognostic in the Adjuvant Setting of Resectable High-Risk Melanoma but Not in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (7) (2019)
Johan Filip Vansteenkiste, Charlotte Van De Kerkhove, Els Wauters, Pierre Van Mol
Capmatinib for the treatment of non-small cell lung cancer. Expert review of anticancer therapy 19 (8) (2019)
Diether Lambrechts, Els Wauters, Bram Boeckx, Sara Aibar, David Nittner, Oliver Burton, Ayse Bassez, Herbert Decaluwé, Andreas Pircher, Kathleen Van den Eynde, Birgit Weynand, Erik Verbeken, Paul De Leyn, Adrian Liston, Johan Filip Vansteenkiste, Peter Carmeliet, Stein Aerts, Bernard Thienpont
Phenotype molding of stromal cells in the lung tumor microenvironment. Nature medicine 24 (8) (2018)

Johan Filip Vansteenkiste.css-eqlu8i{font-size:small;padding-left:4px;} (Johan Vansteenkiste, Johan F Vansteenkiste)

Publication Activity (10 Years)

Top Topics

Top Venues

Johan Filip Vansteenkiste (Johan Vansteenkiste, Johan F Vansteenkiste)